Filing Details

Accession Number:
0001104659-24-081516
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-22 16:30:11
Reporting Period:
2024-07-19
Accepted Time:
2024-07-22 16:30:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1819576 Liquidia Corp LQDA Pharmaceutical Preparations (2834) 851710962
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1935638 Rajeev Saggar 419 Davis Drive
Suite 100
Morrisville NC 27560
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-07-19 1,873 $11.13 208,329 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.
  2. These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on July 18, 2022.
  3. Includes (i) 23,458 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 52,082 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 56,492 RSUs granted to the Reporting Person on January 11, 2024, none of which have vested as of the date of this Form 4 and (iv) 3,604 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.